DOI: 10.1192/j.eurpsy.2026.11149 ISSN: 0924-9338

Adherence to STOMP principles in CAMHS learning disability services: a clinical audit of prescribing, monitoring, and multidisciplinary practice

B. T. Kece, K. Powell

Introduction

Psychotropic over-prescription in people with learning disability remains a global concern. STOMP promotes lowest-effective-dose prescribing, psychosocial support, and regular review. We audited two CAMHS LD services (Hereford and Worcester) against STOMP standards.

Objectives

To compare: (1) documentation of indication and reduce/stop plans; (2) specialist initiation; (3) MDT involvement at initiation and review; (4) review frequency; (5) antipsychotic monitoring; (6) behavioural/psych support; and (7) capacity/best-interests documentation.

Methods

Retrospective case-note review using a standard pro-forma. Hereford: 20 young people (8-17y) and Worcester: 12 young people (8-17y) with moderate-severe LD with or without autism on psychotropics were randomly selected. Data was collected on: specialist initiation, reduce/stop plan, MDT input, review interval, behavioural plan, capacity/best-interests and rationale documentation along baseline/ongoing monitoring.

Results

Prescribing was specialist-initiated with rationale documented in both counties (Hereford, 90%; Worcester, 100%). Reduce/stop plans were rare (Hereford, 10%; Worcester, 17%). MDT involvement at initiation was limited in Hereford (30%) but registered more in Worcester (67%). Ongoing MDT reviews were absent in both counties. Antipsychotic use was higher in Hereford (70%) than Worcester (50%). Monitoring was complete for most in Hereford (79%) and Worcester (83%). Capacity/best-interest documentation in Worcester was fully consistent (100%) but lower in Hereford (60%). Review intervals aligned with guidance.

Table 1.

Comparative findings

Table 1. Long description.

Metric
Hereford (N=20)
Worcester (N=12)
Rationale documented
18/20 (90%)
12/12 (100%)
Reduce/stop plan
2/20 (10%) 2/12 (17%)
MDT at initiation
6/20 (30%) 8/12 (67%)
Ongoing MDT review
0/20 (0%) 0/12 (0%)
Review <=6 months
20/20 (100%) 12/12 (100%)
Antipsychotic use
14/20 (70%) 6/12 (50%)
Monitoring complete
11/14 (79%) 5/6 (83%)
Behavioural/psych plan
6/20 (60%) 5/12 (41%)
Capacity/best-interests
12/20 (60%) 12/12 (100%)

Conclusions

Implementing the same audit in two CAMHS LD services revealed shared strengths (specialist initiation, clear rationale, timely reviews) and persistent gaps (limited de-prescribing plans, variable behavioural support, incomplete monitoring/documentation for a minority). Differences likely reflect local structures: Worcester showed stronger initiation stage with MDT discussions and capacity/best-interests recording, whereas Hereford showed clearer antipsychotic monitoring completion. Quality-improvement actions include embedding a mandatory “medication review” field in MDT pro forma, scheduled MDT follow-ups, standardised monitoring systems within the Trust, and strengthening pathways to psychological and behavioural support. These recommendations align with NHS England STOMP guidance.

Disclosure of Interest

None Declared

More from our Archive